Abbott Said To Acquire First U.S. Production Facility In Russia
This article was originally published in PharmAsia News
Executive Summary
Abbott Laboratories reportedly plans to buy a Russian production facility in a deal that could rank as the nation's third largest pharmaceutical acquisition.